AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Introduction
This chapter discusses the development of CAR T cell therapy for blood cancer and the need for better quality control. It also features an interview with the CSO of MD10 highlighting the importance of lag-3 in immunotherapy.